Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Zhao, Jiajun  [Clear All Filters]
2024
Fan X, Song Y, Zhao J. Evolving liver disease insights from NAFLD to MASLD. Trends Endocrinol Metab. 2024.
Fan X, Zhang B, Shi Y, Liu L, Zhao J. Systemic metabolic Abnormalities: Key drivers of complications and mortality in MASLD. J Hepatol. 2024.
Peng L, Luan S, Shen X, Zhan H, Ge Y, Liang Y, Wang J, Xu Y, Wu S, Zhong X, et al. Thyroid hormone deprival and tsh/tshr signaling deficiency lead to central hypothyroidism-associated intestinal dysplasia. Life Sci. 2024:122577.
2023
Dong Y, Cheng Y, Feng X, Yuan Z, Dong H, Zhang Y, Han J, Wu Y, Wang Z, Zhong X, et al. Association of obesity under different metabolic status with adverse outcomes in patients with chronic myeloid leukemia: A retrospective cohort study. J Diabetes. 2023.
Liu M, Liu L, Guo H, Fan X, Liu T, Xu C, He Z, Song Y, Gao L, Shao S, et al. Dominant-negative HNF1α mutant promotes liver steatosis and inflammation by regulating hepatic complement factor D. iScience. 2023;26(10):108018.
Fan X, Han J, Zhao E, Fang J, Wang D, Cheng Y, Shi Y, Wang Z, Yao Z, Lu P, et al. The effects of obesity and metabolic abnormalities on severe COVID-19-related outcomes after vaccination: A population-based study. Cell Metab. 2023.
Zhang W, Du J, Dong H, Cheng Y, Zhong F, Yuan Z, Dong Y, Wang R, Mu S, Zhao J, et al. Obesity Metabolic Phenotypes and Unplanned Readmission Risk in Diabetic Kidney Disease: An Observational Study from the Nationwide Readmission Database. Arch Med Res. 2023;54(6):102840.
Yu H, Li C, Wu H, Xia W, Wang Y, Zhao J, Xu C. Pathogenic mechanisms of osteogenesis imperfecta, evidence for classification. Orphanet J Rare Dis. 2023;18(1):234.